Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy

Eflapegrastim-xnst, administered same day as TC chemotherapy was effective and well tolerated evidenced by short time to neutrophil recovery and low incidence of FN, with an adverse event profile similar to that of next-day dosing.